Stay updated on Azacitidine, Venetoclax, Pevonedistat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine, Venetoclax, Pevonedistat Clinical Trial page.

Latest updates to the Azacitidine, Venetoclax, Pevonedistat Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedOn the Record History page for NCT03862157, a new entry 'Revision: v3.3.3' was added under revisions, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. These are minor site maintenance and release-note updates that do not affect trial data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe history list adds a new revision entry v3.3.2 and removes v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the government funding status notice that was displayed at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedThe version history page shows minor formatting and layout updates. Core content, dates, and study details appear unchanged.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference11%

- Check104 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Azacitidine, Venetoclax, Pevonedistat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine, Venetoclax, Pevonedistat Clinical Trial page.